Seamus O’Hara
Angel Investor
Dublin, Ireland
Seamus O’Hara is a Partner of Seroba Kernel Life Sciences Limited and was a co-founder of Seroba. He has a background in R&D in the pharmaceutical industry and commercialisation of technology from Irish universities. Since 2002 Seamus has been an active venture investor with Seroba and sits on the Boards of portfolio companies OpsonaTherapeutics, Alimentary Health and Novate Medical, and is an Observer to the Board of Labcyte, Inc. He is also a Director and co-founder of BioConnect Ireland, the leading networking association in the life science sector in Ireland.Seamus previously held a variety of positions in the pharmaceutical industry with AstraZeneca, GlaxoSmithKline and Eli Lily. Seamus also held the position of Business Development Manager with BioResearch Ireland, an Irish Government agency supporting the commercialisation of technology from Irish universities.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Seamus O’Hara?
Public channels for Seamus O’Hara include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
